A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients ...
Patients who have a stent implanted to open a blocked coronary artery face dual risks of developing blood clots and of having excessive bleeding in ...
Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback